News

All News

Press Releases

Media

All Videos

Digital Detail

Independent Corner

Insights

Interviews

Medical World News

Microsites

Peer Exchange

Perfect Consult

Podcasts

Practice Pearls

Student Voices

Webinars/Webcasts

Conferences

Conference Coverage

Conference Listing

Publications

Pharmacy Times

Pharmacy Practice in Focus: Oncology

Pharmacy Practice in Focus: Health Systems

Pharmacy Careers

All Publications

About the Publications

Author Submission

Submit a Manuscript

Become a Peer Reviewer

Clinical

503B Compounding Pharmacy

ADHD

Allergy

Alzheimer Disease

Anxiety

Asthma

Atopic Dermatitis

Biosimilars

Bipolar Disorder

Brain Health

Breast Cancer

C. Difficile

COPD

Cardiovascular Health

Cervical Cancer

Cholangiocarcinoma

Chronic Kidney Disease

Chronic Lymphocytic Leukemia

Colorectal Cancer

Coronavirus

Cough and Cold

Depression

Dermatology

Diabetes

Digestive Health

Dry Eye Disease

Epilepsy

Eye Care

FDA Updates

Future of Pharmacy

Gastrointestinal Cancer

Gastrointestinal Health

Gout

Heart Failure

Hematology

Hepatitis

IVIG

Immunization

Immuno-oncology

Infectious Disease

Lung Cancer

Lymphoma

Macular Degeneration

Mental Health

Migraine

Multiple Myeloma

Multiple Sclerosis

Neurology

Neutropenia

Osteoporosis

Ovarian Cancer

Pain Management

Parkinson Disease

Pediatrics

Pharmacy Heroes

Pharmacy Management

Pneumococcal

PrEP

Prostate Cancer

Psoriasis

Psoriatic Arthritis

Psychedelics

Reimbursement

Reproductive Health

Respiratory Syncytial Virus

Rheumatoid Arthritis

Schizophrenia

Skin Cancer

Sleep

Veterinary Pharmacy

Vitamins and Supplements

Weight Management

Women's Health

Zoster

Events

Upcoming Events

Upcoming Webinars

CME/CE

Resources

Clinical Forum

Cou-Co

Educated Patient

Information for the Pharmacist

Interactive Tools

Partners

Whiteboards

Subscribe

Articles

Compared with placebo, acalabrutinib plus standard of care chemoimmunotherapy demonstrated better progression-free survival in patients with mantle cell lymphoma.

Acalabrutinib Demonstrates Improvements in PFS in Patients With Previously Untreated MCL

As pharmacy practice continues to evolve, it is imperative to recognize the vital contributions of all members of the pharmacy team, including pharmacy technicians.

Elevating Pharmacists, Empowering Pharmacy Technicians: A Symbiotic Journey in Health Care Excellence

With gene therapy, anti-tissue factor pathway inhibitors, and RNA interference therapy targeting antithrombin, there are many new options that will be available for the patients impacted by hemophilia. 

Treatment Options for Hemophilia A and B

CAR T-cells specifically targeting FCRL5, when integrated with IL-15, may improve cytotoxicity, thereby enhancing the therapeutic potency of these cells.

FCRL5-Directed CAR T-Cell Therapy: A Novel Therapeutic Approach for Multiple Myeloma

Pharmacy Times offers the latest news and insights for the pharmacy professional and solutions that impact the everyday practice of pharmacy.

Supporting the Utilization of the Omnipod® 5 Automated Insulin Delivery System